Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial-Mesenchymal Transition

被引:29
作者
Cai, Jiejie [1 ]
Chen, Xiao [2 ]
Chen, Xingxing [3 ]
Chen, Lingzhi [4 ]
Zheng, Gaoshu [3 ]
Zhou, Xi [5 ]
Zhou, Hao [3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Wenzhou, Peoples R China
[2] Ningbo First Hosp, Dept Cardiol, Ningbo, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325000, Peoples R China
[4] Wenzhou Cent Hosp, Dept Clin Lab, Wenzhou, Peoples R China
[5] Wenzhou Med Univ, Affiliated Hosp 1, Dept Coronary Care Unit, Wenzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Relaxin; Spironolactone; Cardiac fibrosis; Transforming growth factor beta; Endothelial-mesenchymal transition; CARDIAC FIBROSIS; KIDNEY FIBROSIS; ACTIVATION; REVERSAL; GAMMA;
D O I
10.1159/000464125
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Background: The effect of relaxin and spironolactone combined on myocardial fibrosis has not been reported. Thus, we investigated the effect of the combined therapy on isoprenaline-induced myocardial fibrosis and the mechanism. Methods: Rats were injected subcutaneously with isoprenaline to induce myocardial fibrosis and underwent subcutaneous injection with relaxin (2 mu g.kg(-1).d(-1)) and given a gavage of spironolactone (30 mg.kg(-1).d(-1)) alone or combined for 14 days. In vitro, the endothelial mesenchymal transition was induced with transforming growth factor beta (TGF-beta) in human umbilical vein endothelial cells (HUVECs) pretreated with relaxin, 200 ng/ml, and/or spironolactone, 1uM. Results: Relaxin and spironolactone used alone or combined improved cardiac function and decreased cardiac weight indices; reduced fibrous tissue proliferation; reduced levels of type I and III collagen; decreased the expression of a smooth muscle actin (alpha-SMA) and transforming growth factor-beta 1 (TGF-beta 1), and increased the expression of cluster of differentiation-31 (CD31) in rats with isoprenaline-induced myocardial fibrosis. In vitro, compared with TGF-beta treatment, relaxin and spironolactone used alone or combined with TGF-beta decreased cell mobility, a-SMA and vimentin levels but increased vascular endothelial cadherin (VE-cadherin) and endothelial CD31levels. Especially, combined therapy had more remarkable effect than relaxin and spironolactone used alone both in vitro and in vivo. Conclusion: Relaxin and spironolactone combined affected isoprenaline-induced myocardial fibrosis in rats that the mechanism might be inhibition of the cardiac endothelial mesenchymal transition. (C) 2017 The Author(s)
引用
收藏
页码:1167 / 1178
页数:12
相关论文
共 24 条
[1]
ANTIFIBROTIC EFFECTS OF SPIRONOLACTONE IN PREVENTING MYOCARDIAL FIBROSIS IN SYSTEMIC ARTERIAL-HYPERTENSION [J].
BRILLA, CG ;
MATSUBARA, LS ;
WEBER, KT .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) :A12-A16
[2]
Brown L, 1999, J AM SOC NEPHROL, V10, pS143
[3]
TEMPORAL DIFFERENCES IN FIBROBLAST PROLIFERATION AND PHENOTYPE EXPRESSION IN RESPONSE TO CHRONIC ADMINISTRATION OF ANGIOTENSIN-II OR ALDOSTERONE [J].
CAMPBELL, SE ;
JANICKI, JS ;
WEBER, KT .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (08) :1545-1560
[4]
Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction [J].
Cheng, Mian ;
Wu, Gang ;
Song, Yue ;
Wang, Lin ;
Tu, Ling ;
Zhang, Lizhi ;
Zhang, Cuntai .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (05) :1928-1938
[5]
Involvement of Endoplasmic Reticulum Stress in Uremic Cardiomyopathy: Protective Effects of Tauroursodeoxycholic Acid [J].
Ding, Wei ;
Wang, Bin ;
Zhang, Minmin ;
Gu, Yong .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (01) :141-152
[6]
Cardiovascular effects of relaxin: from basic science to clinical therapy [J].
Du, Xiao-Jun ;
Bathgate, Ross A. D. ;
Samuel, Chrishan S. ;
Dart, Anthony M. ;
Summers, Roger J. .
NATURE REVIEWS CARDIOLOGY, 2010, 7 (01) :48-58
[7]
Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype [J].
Du, XJ ;
Samuel, CS ;
Gao, XM ;
Zhao, L ;
Parry, LJ ;
Tregear, GW .
CARDIOVASCULAR RESEARCH, 2003, 57 (02) :395-404
[8]
Fibroblast-mediated pathways in cardiac hypertrophy [J].
Fujiu, Katsuhito ;
Nagai, Ryozo .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 70 :64-73
[9]
Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661
[10]
Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal Transition From Cardiovascular Development to Disease [J].
Kovacic, Jason C. ;
Mercader, Nadia ;
Torres, Miguel ;
Boehm, Manfred ;
Fuster, Valentin .
CIRCULATION, 2012, 125 (14) :1795-1808